RecallRadar

FDA Device recall Z-1705-2020

Oncomine Dx Target Test RNA Control- IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens, Cat…

On 2020-04-22 the FDA classified a Class II recall of Oncomine Dx Target Test RNA Control- IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens, Cat… by Life Technologies, citing extended Expiration Date prior to clearance.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1705-2020
ClassificationClass II
Statusterminated
Initiated2020-03-16
Published2020-04-22
Last updated2026-09-13 11:55 UTC
CompanyLife Technologies
DistributionUS

Product

Oncomine Dx Target Test RNA Control- IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens, Catalog Number: A32443

Reason

Extended Expiration Date prior to clearance

Identifiers

code_info
Lot Codes: S119_2174739 S119_2108428 P119_2149305 N119_2078114 S218_2069395 V118_1991154 T118_1990946 S118_1988…Lot Codes: S119_2174739 S119_2108428 P119_2149305 N119_2078114 S218_2069395 V118_1991154 T118_1990946 S118_1988603 P118_1996940 S117_1988306 UDI: (01)10190302006064

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1705-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.